Real-world evidence (RWE) research is an increasingly important component of biopharmaceutical product development and commercialization. The growing industry needs broader information on real-world effectiveness and safety, both of which will impact the eventual reimbursement and utilization of new products and are driven by regulators, public and private payers, and prescribers, all of whom seek to better understand the impact of a new product in a real-world setting.
Clicebo uses Real-world data to
Improve medical care
Reduce costs
Drive better outcomes
We aim to bridge the gap between clinical trials and actual clinical practice by collecting data from various sources such as EHRs, product and disease registries, patient-generated data, and more.
We are dedicated to advance healthcare through the provision of real-world evidence (RWE). Our team of experts collects and analyzes data from multiple sources, including electronic health records and patient-generated data, to provide valuable insights into the real-world effectiveness and safety of treatments.
By leveraging the latest technologies, we help our clients make informed decisions about the development and commercialization of their products. We are committed to delivering reliable and actionable RWE to support the advancement of healthcare and improve patient outcomes.
In this era of advancing technologies, innovative digital data technologies will help optimize the generation of RWE:
.png)
.png)
Adding value with Real World data with
a wide range of services
Burden of Illness Studies
Cost of Illness Analyses
Patient Registries
Patient-centric Outcomes Research
Literature Reviews
Post-approval Safety Surveillance
Cost-effectiveness Studies
PRO (Patient-reported Outcomes) Research
Non-interventional Studies
A host of benefits offered by
Real World Studies
